ArticleCommunications biology2026
Learning brain dynamics across distinct scaling regimes reveals psychiatric signatures.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Understanding how the brain's nonlinear dynamics give rise to cognition remains a central challenge in neuroscience. Conventional neuroimaging methods assume linearity and stationarity, failing to capture frequency-specific neural computations. We introduce Multi-Band Brain Net (MBBN), a transformer-based framework that models frequency-specific spatiotemporal brain dynamics from fMRI. MBBN integrates biologically grounded frequency decomposition with multi-band self-attention, enabling discovery of frequency-dependent network interactions. Trained on 49,673 individuals across three large-scale cohorts (UK Biobank, Adolescent Brain Cognitive Development Study (ABCD), Autism Brain Imaging Data Exchange (ABIDE)), MBBN achieves state-of-the-art performance in predicting psychiatric and cognitive outcomes-including major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), and autism spectrum disorder (ASD)-with AUROC improvements of up to 41.36% alongside strong cognitive intelligence prediction. Frequency-resolved analyses reveal disorder-specific signatures: in ADHD, high-frequency fronto-sensorimotor connectivity is attenuated and opercular somatosensory nodes emerge as dynamic hubs; in ASD, orbitofrontal-somatosensory circuits show focal high-frequency disruption alongside enhanced ultra-low-frequency coupling between the temporo-parietal junction and prefrontal cortex. By combining biologically informed frequency decomposition with transformer architecture, MBBN delivers interpretable biomarkers and improved prediction of psychiatric and cognitive traits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.